Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study

Autor: Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer

Publikováno v: BMJ Open, Vol 12, Iss 2 (2022)

Externí odkaz: https://doaj.org/article/1965d1889ddf4cbeb8a1d66664e6a252

Cytogenetic and molecular analysis of cellular atypical mesoblastic nephroma

Autor: E. van den Berg, Wolter Oosterhuis, N. Van Roy, Catharina Dhooge, Ryj Tamminga, C.R De Potter, Franki Speleman, Marcel M.A.M. Mannens, B. Redeker

Publikováno v: Genes, chromosomes & cancer, 21(3), 265-269. Wiley-Liss Inc.
GENES CHROMOSOMES & CANCER, 21(3), 265-269. Wiley
Genes Chromosomes & Cancer, 21, 265-269. Wiley-Liss Inc.

Cytogenetic and molecular analyses were performed on three cellular (atypical) congenital mesoblastic nephromas (CMNs). Two cases had trisomy 11; in one, it was the sole karyotypic abnormality, and the other had additional numerical changes as well a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7678c362170407efa331756f244cda70
https://pure.amc.nl/en/publications/cytogenetic-and-molecular-analysis-of-cellular-atypical-mesoblastic-nephroma(326bbb13-561b-4cb7-832b-bec9fe7655bf).html

Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects.

Autor: Blaauwgeers MW; Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands., Kruip MJHA; Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Beckers EAM; Department of Hematology, Maastricht University Medical Center, Maastricht, the Netherlands., Coppens M; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Eikenboom J; Department of Internal Medicine, division of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, the Netherlands., van Galen KPM; Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands., Tamminga RYJ; Department of Pediatric Hematology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, the Netherlands., Urbanus RT; Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.; Van Creveld Laboratory, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands., Schutgens REG; Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.

Publikováno v: American journal of hematology [Am J Hematol] 2020 Oct; Vol. 95 (10), pp. 1142-1147. Date of Electronic Publication: 2020 Jul 14.

Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency.

Autor: van Asten I; Van Creveld Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands.; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Blaauwgeers M; Van Creveld Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Granneman L; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Heijnen HFG; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Kruip MJHA; Department of Haematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Beckers EAM; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands., Coppens M; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, The Netherlands., Eikenboom J; Department of Internal Medicine, Division of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands., Tamminga RYJ; Department of Pediatric Hematology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands., Pasterkamp G; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Huisman A; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Galen KPM; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Korporaal SJA; Center for Circulatory Health, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Laboratory of Experimental Cardiology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Schutgens REG; Van Creveld Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Urbanus RT; Van Creveld Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.; Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Haematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Mar; Vol. 18 (3), pp. 706-713. Date of Electronic Publication: 2019 Dec 27.

Congenital platelet disorders and health status-related quality of life.

Autor: Blaauwgeers MW; Van Creveldkliniek University Medical Center Utrecht University Utrecht Utrecht The Netherlands., Kruip MJHA; Department of Haematology Erasmus University Medical Center Rotterdam The Netherlands., Beckers EAM; Department of Hematology Maastricht University Medical Center Maastricht The Netherlands., Coppens M; Department of Vascular Medicine Amsterdam Cardiovascular Sciences Amsterdam University Medical Center Amsterdam The Netherlands., Eikenboom J; Department of Internal Medicine Division of Thrombosis and Haemostasis Leiden University Medical Center Leiden The Netherlands., van Galen KPM; Van Creveldkliniek University Medical Center Utrecht University Utrecht Utrecht The Netherlands., Tamminga RYJ; Department of Pediatric Hematology Beatrix Children's Hospital University Medical Center Groningen Groningen The Netherlands., Urbanus RT; Van Creveldkliniek University Medical Center Utrecht University Utrecht Utrecht The Netherlands.; Van Creveld Laboratory University Medical Center Utrecht University Utrecht Utrecht The Netherlands., Schutgens REG; Van Creveldkliniek University Medical Center Utrecht University Utrecht Utrecht The Netherlands.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2019 Dec 11; Vol. 4 (1), pp. 100-105. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2020).